Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma
Conditions
- Aggressive Non-Hodgkin Lymphoma
- Indolent Non-Hodgkin Lymphoma
- Recurrent Diffuse Large B-Cell Lymphoma
- Recurrent Follicular Lymphoma
- Recurrent Mantle Cell Lymphoma
- Recurrent Marginal Zone Lymphoma
- Recurrent Non-Hodgkin Lymphoma
- Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma
- Recurrent T-Cell Non-Hodgkin Lymphoma
- Small Lymphocytic Lymphoma
Interventions
- PROCEDURE: Cryosurgery
- BIOLOGICAL: Dendritic Cell Therapy
- OTHER: Laboratory Biomarker Analysis
- BIOLOGICAL: Pembrolizumab
- BIOLOGICAL: Pneumococcal 13-valent Conjugate Vaccine
- OTHER: Quality-of-Life Assessment
Sponsor
Mayo Clinic
Collaborators